Johnson & Johnson has accused a long-standing employee of taking thousands of confidential files about commercial strategies as he left for a similar job at Pfizer, according to lawsuit filed in a federal court in New Jersey.
The health care giant alleged that Andrew Brackbill, who most recently worked in the Strategic Customer Group as director of trade channel strategy, downloaded files containing 10-year business plans across different therapeutic product areas; product launch strategies; market access assessments; the details of relationships with distributors; and clinical studies, among other things.
This unit within J&J is responsible for creating and formulating competitive strategies for J&J’s products through their lifecycle. The work includes establishing distribution channels, pricing, strategic account management, and contracting across the portfolio of medicines, according to the lawsuit. Brackbill, who joined J&J in the finance department in 1999, joined this group in 2021.
This article is exclusive to STAT+ subscribers
Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.
Already have an account? Log in
Already have an account? Log in
About the Author Reprints
To submit a correction request, please visit our Contact Us page.
STAT encourages you to share your voice. We welcome your commentary, criticism, and expertise on our subscriber-only platform, STAT+ Connect